alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
exhibit10-5.htm


Convertible Promissory Note





December 16, 2009 US$82,500









TO:           Blue Cove Holdings Inc. of # 4 Beaufort Road, Nassau, Bahamas (the “Creditor”)





WHEARAS:






	
A.
	
Endeavor Explorations Inc is indebted to the Creditor in the amount of $75,000 for the aggregate funds that the Creditor previously advanced to Endeavor;









	
B.
	
as consideration for a further advance of $7,500, Endeavor agrees to combine all previous indebtedness into this Note payable pursuant to the terms and conditions provided in this Note;








Endeavor Explorations Inc. of 980 Cooperage Way, Suite 601, Vancouver, British Columbia, V6B 0C3 (“Endeavor”), promises to pay to the Creditor, at the address
specified above, the principal amount specified below (the “Principal”).





The following are the terms and conditions of the Note:






	
  
	
1.
	
Principal amount:
	
$82,500 due and payable from Endeavor to the Creditor.









	
  
	
2.
	
Maturity date:
	
This Note will be payable on demand.









	
  
	
3.
	
Interest:
	
No interest will accrue on the outstanding amount.









	
  
	
4.
	
Conversion:
	
At any time prior to the date that the Principal is repaid, the Creditor, at its sole option, may convert a portion or all of the Principal outstanding into shares of common stock in the capital stock of Endeavor (the “Shares”).  Each $0.05 of Principal outstanding may be converted into one Share.









	
  
	
5.
	
Currency:
	
All funds and dollar amounts referred to in this Note are in the lawful currency of the United States of America.









	
  
	
6.
	
Jurisdiction:
	
This Note will be interpreted in accordance with the laws in effect from time to time in the Province of British Columbia.









	
  
	
7.
	
Resale Restrictions:
	
If the Creditor chooses to convert the Principal into Shares pursuant to paragraph 4, the Creditor agrees and acknowledges that it will comply with all securities laws relating to resale restrictions.








IN WITNESS WHEREOF this Promissory Note has been executed as of the day and year first above written.









Endeavor Explorations Inc.





Per:           /s/ Belkis Jimenez Rivero

_______________________________

Belkis Jimenez Rivero

CEO & President
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Northeast Area
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        
                Northeast Area Cities

                    Washington, D.C.
                            Newark, Delaware
                            Boston, Massachusetts
                            Beltsville, Maryland (BHNRC)
                            Beltsville, Maryland (BARC)
                            Frederick, Maryland
                            Orono, Maine
                            Geneva, New York
                            Ithaca, New York
                            University Park, Pennsylvania
                            Wyndmoor, Pennsylvania
                            Kearneysville, West Virginia
                            Leetown, West Virginia
                            Burlington, Vermont


                    Civil Rights & EEO Policy StatementsSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Docs





- Searchable Databases
- Datasets and Models
- Insect and Pathogen Identification
- Biocontrol FAQs 4 Kids
- BA Internet Classroom
- Harvest for the Hungry: Gleaning at Beltsville
- Weather Data

testingheadline bar  Font font font font


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             DEC-26-1999
<PERIOD-END>                               APR-01-2000
<CASH>                                             581
<SECURITIES>                                         0
<RECEIVABLES>                                    1,072
<ALLOWANCES>                                         0
<INVENTORY>                                     32,023
<CURRENT-ASSETS>                                38,909
<PP&E>                                          16,000
<DEPRECIATION>                                   6,718
<TOTAL-ASSETS>                                  54,704
<CURRENT-LIABILITIES>                           16,794
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            72
<OTHER-SE>                                      21,101
<TOTAL-LIABILITY-AND-EQUITY>                    54,704
<SALES>                                         23,370
<TOTAL-REVENUES>                                23,370
<CGS>                                           11,467
<TOTAL-COSTS>                                    9,891
<OTHER-EXPENSES>                                 2,324
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 343
<INCOME-PRETAX>                                  (655)
<INCOME-TAX>                                     (262)
<INCOME-CONTINUING>                              (393)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (393)
<EPS-BASIC>                                     (0.06)
<EPS-DILUTED>                                   (0.06)


</TABLE>
[Federal Register Volume 86, Number 128 (Thursday, July 8, 2021)]
[Notices]
[Pages 36172-36173]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14580]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Extension: Rule 17g-5, OMB Control No. 3235-0649]


Submission for OMB Review; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange 
Commission, Office of FOIA Services, 100 F Street NE, Washington, DC 
20549-2736

    Notice is hereby given that pursuant to the Paperwork Reduction Act 
of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange 
Commission (``Commission'') has submitted to the Office of Management 
and Budget (``OMB'') a request for approval of extension of the 
previously approved collection of information provided for in Rule 17g-
5 (17 CFR 240.17g-5) under the Securities Exchange Act of 1934 (15 
U.S.C. 78a et seq.) (``Exchange Act'').
    Rule 17g-5 requires the disclosure of and establishment of 
procedures to manage certain NRSRO conflicts of interest, prohibits 
certain other NRSRO conflicts of interest, and contains requirements 
regarding the disclosure of information in the case of the conflict of 
interest of an NRSRO issuing or maintaining a credit rating on an 
asset-backed security that was paid for by the issuer, sponsor, or 
underwriter of the security. The Commission currently estimates that 
the total annual burden for respondents to comply with Rule 17g-5 is 
263,306 hours.
    An agency may not conduct or sponsor a collection of information 
unless it displays a currently valid OMB control number. No person 
shall be subject to any penalty for failing to comply with a collection 
of information subject to the PRA that does not display a valid OMB 
control number.
    The public may view background documentation for this information 
collection at the following website:

[[Page 36173]]

>www.reginfo.gov<. Find this particular information collection by 
selecting ``Currently under 30-day Review--Open for Public Comments'' 
or by using the search function. Written comments and recommendations 
for the proposed information collection should be sent within 30 days 
of publication of this notice to (i) >www.reginfo.gov/public/do/PRAMain< and (ii) David Bottom, Director/Chief Information Officer, 
Securities and Exchange Commission, c/o Cynthia Roscoe, 100 F Street 
NE, Washington, DC 20549, or by sending an email to: 
<a href="/cdn-cgi/l/email-protection#623230233d2f030b0e000d1a221107014c050d14"><span class="__cf_email__" data-cfemail="e4b4b6a5bba9858d88868b9ca4978187ca838b92">[email protected]</span></a>.

    Dated: July 2, 2021.
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2021-14580 Filed 7-7-21; 8:45 am]
BILLING CODE 8011-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE>                           5
<LEGEND>
</LEGEND>
<CIK>                                 0001030418
<NAME>                               BIONX IMPLANTS,INC.
<MULTIPLIER>                                              1,000
<CURRENCY>                                                US
<S>                                     <C>

<PERIOD-TYPE>                           9-MOS
<FISCAL-YEAR-END>                                         DEC-31-1998
<PERIOD-END>                                              SEP-30-1999
<EXCHANGE-RATE>                                             1
<CASH>                                                      2,926
<SECURITIES>                                                    0
<RECEIVABLES>                                               3,794
<ALLOWANCES>                                                  394
<INVENTORY>                                                13,426
<CURRENT-ASSETS>                                           22,251
<PP&E>                                                      3,321
<DEPRECIATION>                                              1,585
<TOTAL-ASSETS>                                             29,397
<CURRENT-LIABILITIES>                                       4,891
<BONDS>                                                         0
<PREFERRED-MANDATORY>                                           0
<PREFERRED>                                                     0
<COMMON>                                                       17
<OTHER-SE>                                                 24,429
<TOTAL-LIABILITY-AND-EQUITY>                               29,397
<SALES>                                                    14,917
<TOTAL-REVENUES>                                           15,173
<CGS>                                                       4,763
<TOTAL-COSTS>                                              16,830
<OTHER-EXPENSES>                                                0
<LOSS-PROVISION>                                                0
<INTEREST-EXPENSE>                                           (709)
<INCOME-PRETAX>                                            (5,711)
<INCOME-TAX>                                                    0
<INCOME-CONTINUING>                                             0
<DISCONTINUED>                                                  0
<EXTRAORDINARY>                                                 0
<CHANGES>                                                       0
<NET-INCOME>                                               (5,761)
<EPS-BASIC>                                                 (0.65)
<EPS-DILUTED>                                               (0.65)



</TABLE>
### IN THE UNI TED STAT ES COURT OFAPPEALS FOR THE FIF TH CIRCU IT

No. 10-30963 Summary Calendar

ALVIN MEAD, Petitioner-Appellant

v. BURL CAIN, WARDEN, LOUISIANA STATE PENITENTIARY, Respondent-Appellee
Appeal from the United States District Court for the Eastern District of Louisiana USDC No. 2:08-CV-3173
Before REAVLEY, SMITH, and PRADO, Circuit Judges. PER CURIAM: * Alvin Mead, Louisiana prisoner # 310779, appeals the denial of his second 28 U.S.C. § 2254 application challenging his conviction for possession of cocaine. The district court denied the application as time barred but neve rth e l e s s gr a nt ed Mead a certificate of appealability on his claim of actual innocence. If necessary, we must exami n e the basis of our jurisdiction sua sponte. Mosley v. Cozby , 813 F.2d 659, 660 (5th Cir. 1987). Mead’s sec o nd § 2254 application raised a claim of actual innocence that could have been raised in his U n i te d S ta te s C o u rt o f A p p ea l s

F i ft h C i rc u i t 

### F I L E D August 22, 20 11 Lyle W . Cayce Clerk

Purs uant to 5 T H C IR

. R. 47.5 , the cour t has d ete rm inedt hat this op inion sho uld not * be publ ish ed and is not pr ece dent excep t unde r the lim ite d cir cum st ance s se t for th in 5 T H C IR

. R. 47.5 .4. Case: 10-30963 Document: 00511578801 Page: 1 Date Filed: 08/22/2011No. 10-30963

earlier application; therefore, the second application was successive. See Crone v. Cockrell , 324 F.3d 833, 836 (5th Cir. 200 3). As a prisoner seeking to file a second o r s u ccessive § 2254 application, Mead was required to apply for leave from this court. 28 U.S.C. § 2244(b)(3)(A). H i s failure to do so rendered his second application unauthorized, thus dep rivin g the district court of jurisdiction

. See United States v. Key , 205 F.3d 773, 774 (5th Cir. 2000). As such, we lack jurisdiction over this habeas appeal. See id. at 775. The judgment of the district court is t h us VACATED, and the appeal is DISMISSED for lack of jurisdiction.

2 Case: 10-30963 Document: 00511578801 Page: 2 Date Filed: 08/22/2011
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 13

- 987 V

Filed: November 25, 2014

Not for P ublication

*************************************

HUGO D. GUTIERREZ

, *

*

Petitioner, *

* Damages decision based on stipulation;

v. * influenza (flu) v accine; Guillain

- Barré

* Syndrome (GBS)

SECRETARY OF HEA LTH *

AND HUMAN SERVICES, *

*

Respondent. *

*

*************************************

Peter M. Young

, Wa u sau, WI

, for petitioner

. Justine E. Daigneault , Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING DAMAGES 1

On November 24 , 2014 , the parties filed the attached stipulation in which they agreed to

settle this case and described t he settlement terms. Petitioner allege s that he suffers from

G uillain

- Barré Syndrome (“GBS”) that was caused by his receipt of influenza (“flu”) vaccine on

December 27, 2010

. Respondent denies that the flu vaccine caused petit ioner ’ s GBS, any other

injury, or his current condition

. Nonetheless, the parties agreed to resolve this matter informally.

1 Because this unpublished decision contains a reasoned exp lanation for the special master’ s action in this

case, the special master intends to post this unpublished decision on the United States Court of Federal

Claims’ website, in accordance with the E

- Government Act of 2002, Pub. L. No. 107

- 347, 116 Stat. 2899,

2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made

available to the public u nless they contain trade secrets or commercial or financial information that is

privileged and confidential, or medical or similar information whose disclosure would constitute a clearly

unwarranted invasion of privacy. When such a decision is filed, peti tioner has 14 days to identify and

move to delete such information prior to the document ’ s disclosure. If the special master, upon review,

agrees that the identified material fits within the banned categories listed above, the special master shall

delete such material from public access.2

The undersigned finds the terms of the stipulation to be reasonable. The court hereby

adopts the parties ’ said stipulation, attached hereto, and awards compensation in the amount and

o n the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of

$1 80,000.00 , representing compensation for all damages that would be available under 42 U.S.C.

§ 300aa

- 15(a) (2006 ) . The award shall be in the form of a check for $ 1 80,000.00 payable to

petitioner

.

In the absence of a motion fo r review filed pursuant to RCFC Appendix B, the clerk of the

court is directed to enter judgment herewith. 2

IT IS SO ORDERED.

Dated: November 25, 2014 s/ Laura D. Millman

Laura D. Millman

Special Master

2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party , either separately or

jointly, filing a notice renouncing the right to seek review.
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

GESPA NICARAGUA, S.A.,

Appellant,

v.

RECOM AG, FLEXTRONICS

INTERNATIONAL USA, INC.,

FLEXTRONICS AUTOMOTIVE USA

(TEXAS), LLC, and EXPEDITORS

INTERNATIONAL OF WASHINGTON,

INC.,

Appellees. §

§

§

§

§

§

§

§ No. 08

- 22

- 00244

- CV

Appeal from the

120th Judicial District Court

of El Paso County, Texas

(TC# 2018

- DCV

- 4112)

J U D G M E N T

The Court has considered this cause on the record and concludes the trial court’s judgment

should be affirmed in part and reversed in part

. We reverse the trial court’s June 22, 2022, judgment

dismissing Appellant’s claims against Appellee Expeditors International of Washington, Inc. In

all other respects, the trial court’s orde r is affirmed. We remand this cause to the trial court for

further proceedings consistent with this opinion.

We further order that each party bear its own costs of this appeal. This decision shall be

certified below for observance.

IT IS ORDERED THIS 20 TH DAY OF MARCH 202 4

.

G INA M. PALAFOX , Justice

Before Alley, C.J., Palafox and Soto, JJ.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Vascular and Hematology.                    

*Date:*                         August 23, 2021.                    

*Time:*                         2:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).                    

*Contact Person:*                         Larry Pinkus, Ph.D. Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4132, MSC 7802 Bethesda, MD 20892, (301) 435-1214,                         *pinkusl@csr.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: July 14, 2021. 

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-15329 Filed 7-19-21; 8:45 am]

BILLING CODE 4140-01-P
# C_2020061EN.01003301.xml

| 24.2.2020 | EN | Official Journal of the European Union | C 61/33 |
| --- | --- | --- | --- |

24.2.2020

EN

Official Journal of the European Union

C 61/33

---

Judgment of the General Court of 19 December 2019 — Karlovarské minerální vody v EUIPO — Aguas de San Martín de Veri (VERITEA)

(Case T-28/19) (1)

(EU trade mark - Opposition proceedings - Application for the EU word mark VERITEA - Earlier EU word mark VERI - AGUA PURA DEL PIRINEO - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001 - Obligation to state reasons)

(2020/C 61/40)

Language of the case: English

Parties

Applicant: Karlovarské minerální vody a.s. (Karlovy Vary, Czech Republic) (represented by: J. Mrázek, lawyer)

Defendant: European Union Intellectual Property Office (represented by: L. Lapinskaite, J. Crespo Carrillo and H. O’Neill, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Aguas de San Martín de Veri, SA (Bisaurri, Spain) (represented by: P. González-Bueno Catalán de Ocón, lawyer)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 8 November 2018 (Case R 499/2018-5), relating to opposition proceedings between Aguas de San Martín de Veri and Karlovarské minerální vody.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Karlovarské minerální vody a.s. to pay the costs. |
| --- | --- |

2.

Orders Karlovarské minerální vody a.s. to pay the costs.

---

(1)  OJ C 82, 4.3.2019.

---